EVE Health Group Limited ( (AU:EVE) ) has shared an update.
EVE Health Group Limited reported a decrease in revenue from ordinary activities by 11.4% to $1,006,364 for the period ending December 31, 2024, compared to the previous year. The company also saw a reduction in loss after tax from continuing operations by 21.4% to $678,651, while loss after tax from discontinued operations increased by 50.3% to $128,234. The net loss attributable to members decreased by 15% to $806,885. No dividends were declared during this period. These financial results indicate challenges in maintaining revenue growth, but also reflect efforts to manage losses in continuing operations.
More about EVE Health Group Limited
EVE Health Group Limited is a leading producer of branded nutrition, health, and wellness products with a vertically integrated business model. The company operates globally, focusing on fast-growing markets in Australia, New Zealand, Asia Pacific, and North America. EVE Health Group is committed to creating high-quality, innovative, natural, and sustainable products that enhance consumer wellbeing.
Current Market Cap: A$5.27M
For a thorough assessment of EVE stock, go to TipRanks’ Stock Analysis page.